About Me

As a partner in our Intellectual Property group in London, I am an experienced litigator of complex patent disputes in the life sciences sector.

The focus of my work is on pan-European patent disputes within the pharmaceutical, biological and genetic fields, including litigation pertaining to medical devices. I represent clients before the UK Patents Court, in LCIA arbitration, mediation and oppositions at the European Patent Office.

The nature of patents means I regularly co-ordinate patent litigation strategy with colleagues across Europe, Asia and the United States.

I regularly speak and moderate at conferences on patent law and am a member of the International Association of Intellectual Property, the American Intellectual Property Law Association and the Intellectual Property Institute of Canada.

I hold an MSc in molecular biology and a BSc in genetics from the University of British Columbia, a law degree from Dalhousie University and an LLM from the University of Cambridge. What seems a long time ago, I began my legal career at a leading Canadian IP firm in Toronto.
Experience
  • The Broad Institute (CRISPR): EPO proceedings
  • Actavis v ICOS (tadalafil): Supreme Court
  • Ablynx v Unilever/VHSquared: UK Patents Court
Education

Studied

  • University of Cambridge, LLM
  • Dalhousie University, LLB
  • The University of British Columbia, MSc, Molecular Biology
  • The University of British Columbia, BSc, Genetics

Admissions

  • Solicitor, Law Society of England & Wales, 2005
  • Barrister & Solicitor, Law Society of Upper Canada, 2002
Testimonials Carousel Megaphone

Testimonials

'An accomplished advocate with a strong ability to assess the quality of potential expert witnesses'

IAM Patent 1000 2020

Jennifer Jones stands out as a leading authority on pan-European patent litigation across a wide range of industries within the life sciences sector.

Who's Who Legal 2018

Jenny is very calm under pressure and can provide excellent, up-to-date strategic insight. She is superb in very complex multiparty action cases.

Who's Who Legal 2017

Latest insights

More Insights
spring

Legal priority: EBA decision establishes presumption of validity

Feb 29 2024

Read More
Snow-capped mountain range

Supreme Court holds Dosage Regime Patent Obvious

Mar 27 2019

Read More
City skyline at dusk

Actavis, Teva and Generics t/a Mylan v ICOS and Eli Lilly: Dosage patent for tadalafil for treatment of male erectile dysfunction held invalid for obviousness on appeal

Nov 02 2017

Read More

What's on TwoBirds TV?

More Videos